Hepatología: Biopsia Líquida y Carcinogénesis
HEPACAN
![Foto de Hepatología: Biopsia Líquida y Carcinogénesis](/img/uploaded/0b8b56b038c599385c0455f4992aff41.jpg)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublications en collaboration avec des chercheurs de Instituto de Salud Carlos III (8)
2023
-
Loss of liver function in chronic liver disease: An identity crisis
Journal of Hepatology, Vol. 78, Núm. 2, pp. 401-414
2022
-
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1
2021
-
Armcx3 mediates susceptibility to hepatic tumorigenesis promoted by dietary lipotoxicity
Cancers, Vol. 13, Núm. 5, pp. 1-22
-
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation
Nucleic Acids Research, Vol. 49, Núm. 15, pp. 8592-8609
2016
-
Further evidence on the janus-faced nature of the epidermal growth factor receptor: From liver regeneration to hepatocarcinogenesis
Hepatology, Vol. 63, Núm. 2, pp. 371-374
2015
-
Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14
Hepatology, Vol. 61, Núm. 5, pp. 1755-1757
-
Oxidative Stress Mechanisms in Hepatocarcinogenesis
STUDIES ON HEPATIC DISORDERS (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 449-477
2014
-
Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis
HEPATIC ONCOLOGY, Vol. 1, Núm. 2, pp. 241-252